Join
Live feed
·
INSIDERFilingvia Quantisnow
MAIA Biotechnology Inc. logo

Amendment: Chief Executive Officer Vitoc Vlad bought $79,849 worth of shares (72,000 units at $1.11), increasing direct ownership by 9% to 903,421 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MAIA· MAIA Biotechnology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MAIA (MAIA Biotechnology Inc.) and more on Quantisnow.